


Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival

Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes
Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes